ACVR2A downregulation disrupts the TCF7/c-JUN pathway, impairing trophoblast invasion and proliferation in pre-eclampsia, revealing a genetic susceptibility-associated mechanism of placental ...

Intellia has leveraged its expertise in Crispr/Cas9 gene editing to advance a pipeline of in vivo and ex vivo therapies for diseases with high unmet medical needs. We believe Intellia's proprietary ...

Researchers at the Max Planck Institute for Evolutionary Anthropology have addressed a longstanding challenge in CRISPR ...

Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran 1449614535, Iran Department of Medical Nanotechnology, Faculty of Advanced Technologies in Medicine, Iran University ...

Scientists at the McGovern Institute for Brain Research at MIT and the Broad Institute of MIT and Harvard have re-engineered ...

The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.

This remains challenging owing to the lack of induction methods that imitate the natural programming process. Endogenous gene regulation of tissue-specific transcription factors is therefore desirable ...

Market Segmentation: The report may break down the market into segments based on gene delivery methods (e.g., viral vectors, non-viral vectors), applications (e.g., gene therapy, research, vaccines), ...

Cover Credit: AAV-mediated CAS9 delivery to the hippocampus is drastically improved by opening the blood-brain barrier (BBB). Genome editing has an assured place in the future of therapies for ...

Researchers at the National University of Singapore (NUS) have developed a scalable, non-viral technology that efficiently ...